The amplification of the TRIM37 genome contributes to the tumor progression in colorectal cancer, HCC, lung cancer, neuroblastoma, breast cancer, pancreatic cancer, and osteosarcoma [36,37,38]. This evidence concerns the gene TRIM37 and breast carcinoma.